Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung Cancer
86%
Magnetic Resonance Imaging
82%
Computer Assisted Tomography
71%
Neoplasm
51%
Chemotherapy
48%
Glioblastoma
46%
Overall Survival
44%
Disease Exacerbation
44%
Prostate Cancer
42%
Breast Cancer
42%
Low Drug Dose
40%
Clinical Trial
40%
Non Small Cell Lung Cancer
38%
Emergency Department
31%
Lung Nodule
31%
Treatment Effect
31%
Area under the Curve
31%
Ganglioglioma
30%
Patient Population
30%
Computer-Aided Diagnosis
28%
Epigenetic Therapy
28%
Sunitinib
28%
Non-Hodgkin Lymphoma
28%
Riluzole
28%
Maturity Onset Diabetes of the Young
28%
Cancer
28%
Docetaxel
28%
Castration Resistant Prostate Cancer
28%
Kidney Metastasis
28%
Temozolomide
28%
Cancer Diagnosis
28%
Progression Free Survival
27%
Malignant Neoplasm
25%
Diseases
24%
Diagnostic Accuracy
23%
Treatment Response
22%
Methylation
21%
Biological Marker
21%
Lung Cancer Screening
21%
Non-Small Cell Lung Cancer
20%
Gene Expression
20%
Metastatic Carcinoma
19%
Recurrent Disease
19%
Clinical Study
19%
Outpatient
19%
National Lung Screening Trial
18%
Case-Control Study
17%
Genetics
17%
X-Ray Computed Tomography
17%
Placebo
17%
Keyphrases
Parkinson's Disease
100%
Clinical Trials
93%
Global Test
59%
Unified Parkinson's Disease Rating Scale (UPDRS)
55%
Non-Hodgkin Lymphoma
46%
Non-small Cell Lung Cancer (NSCLC)
44%
Minocycline
42%
Early Parkinson's Disease
42%
Group Visits
42%
Global Assessment
42%
Clinical Outcomes
36%
Vitamin E
34%
Glioblastoma
34%
Tumor
32%
Chemotherapy
32%
Radioimmunotherapy
30%
American Diabetes Association
30%
Overall Survival
29%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
28%
COVID-19
28%
Pemetrexed
28%
Computed Tomography
28%
Epigenetic Therapy
28%
Emergency Department
28%
Breast Cancer
28%
Treatment Effect
27%
Multiple Outcomes
26%
Standard of Care
25%
Deprenyl
25%
Lung Cancer
24%
Placebo
24%
Association Standard
23%
Cancer Treatment
23%
Rituximab
22%
Symptomatic Therapy
21%
Coenzyme Q10
21%
Peripheral Blood
21%
Diagnostic Accuracy
21%
Gene Expression
20%
Patient Outcomes
19%
Breast Density
19%
Prognostic Biomarker
19%
Progression-free Survival
19%
Radiomics
19%
SncRNA
19%
Nonparametric Behrens-Fisher Problem
19%
Cancer Diagnosis
18%
Tumor Tissue
18%
Type 2 Diabetic Patients
18%
Randomized Double-blind
17%